[New drugs with positive inotropic action].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use; D000676:Amrinone; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004983:Ethanolamines / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D011217:Practolol / Q000031:analogs & derivatives / Q000627:therapeutic use; D011294:Prenalterol; D013268:Stimulation, Chemical; D013726:Terbutaline / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000631:Aminopyridines; D002316:Cardiotonic Agents; D004983:Ethanolamines; D000676:Amrinone; D011294:Prenalterol; D013726:Terbutaline; C009118:pirbuterol; D000420:Albuterol; D011217:Practolol
Nowe leki o działaniu inotropowo dodatnim.